Cullinan Therapeutics Inc (CGEM)

Cost of Revenue

$0.00

TTM · Period ending: · USD

CGEM logo

CGEM Cost of Revenue

Latest reported$0.00
CGEM TTM Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

CGEM cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cullinan Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
77,000
153,000
230,000
230,000
153,000
77,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.